Determining a company’s acquisition/merger value requires an intensive due diligence process. Attorney Gregg Metzger discusses salesforce contracts which, especially for life science companies, cannot be overlooked.
Gregg Metzger
Advertisement
Gregg Metzger is Partner at Feldman Gale.
Articles by Gregg Metzger
Advertisement
Latest Updated Articles
Sales Personnel Contracts, Sword or Shield for M&A ValuationPublished: June 16th 2015 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
2
Could DTC Programs Help Simplify the Drug-Pricing System?
3
Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies
4
AI Becomes Pharma’s New Operating System: Q&A with causaLens’ CEO and Co-Founder Darko Matovski
5
